AdipoGen Life Sciences

BMS-3

Product Code:
 
AG-CR1-2901
Product Group:
 
Inhibitors and Activators
Regulatory Status:
 
RUO
Shipping:
 
-20°C
Storage:
 
Short Tem: +4°C Long Term: -20°C
1 / 1
Chemical Structure
❮❯

Chemical Structure

No additional charges, what you see is what you pay! *

CodeSizePrice
AG-CR1-2901-M0055 mg£80.00
Quantity:
AG-CR1-2901-M02525 mg£290.00
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: Switzerland.
Typical lead time: 7-10 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Alternate Names/Synonyms:
N-(5-(1-(2,6-Dichlorophenyl)-3-(difluoromethyl)-1H-pyrazol-5-yl)thiazol-2- yl)cyclopropanecarboxamide
Appearance:
Off-white solid.
CAS:
1338247-30-5
EClass:
32160000
Form (Short):
liquid
Handling Advice:
Keep cool and dry.
InChi:
InChI=1S/C17H12Cl2F2N4OS/c18-9-2-1-3-10(19)14(9)25-12(6-11(24-25)15(20)21)13-7-22-17(27-13)23-16(26)8-4-5-8/h1-3,6-8,15H,4-5H2,(H,22,23,26)
InChiKey:
YBGGBHCJSAEIAS-UHFFFAOYSA-N
Long Description:
Chemical. CAS: 1338247-30-5. Formula: C17H12Cl2F2N4OS. MW: 429.3. Potent LIMK (Lim kinase) inhibitor. Has IC50 values of 5nM and 6nM for LIMK1 and LIMK2, respectively.
MDL:
MFCD17019326
Molecular Formula:
C17H12Cl2F2N4OS
Molecular Weight:
429.3
Package Type:
Vial
Product Description:
Potent LIMK (Lim kinase) inhibitor. Has IC50 values of 5nM and 6nM for LIMK1 and LIMK2, respectively.
Purity:
>98% (HPLC)
SMILES:
ClC1=C(N2C(C3=CN=C(NC(C4CC4)=O)S3)=CC(C(F)F)=N2)C(Cl)=CC=C1
Solubility Chemicals:
Soluble in DMSO (5mg/ml).
Transportation:
Non-hazardous
UNSPSC Category:
Biochemical Reagents
UNSPSC Number:
12352200
Use & Stability:
Stable for at least 2 years after receipt when stored at -20°C.

References

Phenyl-substituted pyrimidine compounds useful as kinase inhibitors: S.T. Wrobelski, et al.; WO2006084017 (2006) | Identification of a nonkinase target mediating cytotoxicity of novel kinase inhibitors: P. Ross-Macdonald, et al.; Mol. Cancer Ther. 7, 3490 (2008)